Drug Discovery and Team Science
In plain English
AI plain-English summaryA new training programme will embed PhD students in multidisciplinary teams, each tackling a specific disease—cancer, pain, respiratory illness, immune-oncology, or inflammation—by combining lab experiments with mathematical modelling. The pharmaceutical industry has identified critical skills gaps in complex animal models and in translating lab findings into real treatments. Most researchers train in a single discipline, but drug discovery requires chemists, biologists, and data scientists to work together from the start. This programme directly addresses that gap by making team science the core of the training, not an afterthought. If successful, the programme will produce a generation of scientists who can move seamlessly between academic labs and industry, accelerating the development of drugs that target membrane receptors—proteins on cell surfaces that are key to many diseases. This could shorten the time from a fundamental discovery to a medicine that reaches patients. The programme also embeds placements in pharmaceutical companies and small biotech firms, so students learn translational skills—communication, leadership, entrepreneurship—that are rarely taught in traditional PhDs. The result is a workforce better equipped to turn biological insights into treatments that change lives.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
PhD Programme in Science (Basic)Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know